Patents by Inventor Reshma A. RANGWALA

Reshma A. RANGWALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240252673
    Abstract: The invention provides methods and compositions for treating cancer, such as advanced cervical cancer, in a subject, such as by the administration of antibody-drug conjugates that bind to tissue factor (TF). The invention also provides articles of manufacture and compositions comprising said antibody drug-conjugates that bind to TF for use in treating cancer (e.g., advanced cervical cancer).
    Type: Application
    Filed: August 17, 2023
    Publication date: August 1, 2024
    Inventors: Reshma A. RANGWALA, Steen LISBY
  • Publication number: 20230263902
    Abstract: The invention provides methods and compositions for treating cancer, such as advanced cervical cancer, in a subject, such as by the administration of antibody-drug conjugates that bind to tissue factor (TF). The invention also provides articles of manufacture and compositions comprising said antibody drug-conjugates that bind to TF for use in treating cancer (e.g., advanced cervical cancer).
    Type: Application
    Filed: June 29, 2021
    Publication date: August 24, 2023
    Inventor: Reshma A. RANGWALA
  • Publication number: 20220387485
    Abstract: The invention provides a platinum-based agent (e.g., carboplatin) in combination with an antibody-drug conjugate that binds to tissue factor (TF) (e.g., tisotumab vedotin) and their use in methods of treating cancer, such as bladder cancer and cervical cancer. The invention also provides compositions and kits comprising the platinum-based agent (e.g., carboplatin) and the antibody-drug conjugate that binds to TF (e.g., tisotumab vedotin) for use in treating cancer, such as bladder cancer and cervical cancer.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 8, 2022
    Applicant: Genmab A/S
    Inventors: Reshma A RANGWALA, Esther C,W. BREIJ, Sandra VERPLOEGEN, Oyewale O. ABIDOYE, Leonardo V. NICACIO
  • Publication number: 20210308208
    Abstract: The invention provides methods and compositions for treating cancer, such as ovarian cancer, peritoneal cancer, and fallopian tube cancer, in a subject, such as by the administration of antibody-drug conjugates that bind to tissue factor (TF). The invention also provides articles of manufacture and compositions comprising said antibody drug-conjugates that bind to TF for use in treating cancer (e.g., ovarian cancer, peritoneal cancer, and fallopian tube cancer).
    Type: Application
    Filed: August 14, 2019
    Publication date: October 7, 2021
    Inventors: Reshma A. RANGWALA, Esther C.W. BREIJ, Sandra VERPLOEGEN, Bart DE GOEIJ, Oyewale O. ABIDOYE, Leonardo V. NICACIO, Stephen C. ALLEY